File: bbe22bvw5_pub_en.pdfTrial reference: A two-part, open-label systemic gene delivery study to evaluate the safety and expression of RO7494222 (SRP-9001) in subjects under the age of four with Duchennne Muscular Dystrophy (ENVOL) Doc type: Information for the public